Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Ocean Biomedical Inc (EM) OCEA

Healthcare Biotechnology
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company’s oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA... see more

Current News (EXPM:OCEA)

Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value

GlobeNewswire April 22, 2025

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

GlobeNewswire March 28, 2025

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

GlobeNewswire February 10, 2025

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

GlobeNewswire January 29, 2025

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

GlobeNewswire November 22, 2024

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

GlobeNewswire October 22, 2024

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

GlobeNewswire October 1, 2024

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company's Malaria Treatment and Prevention Platforms

GlobeNewswire August 27, 2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

GlobeNewswire August 23, 2024
View More News ››

Opinion & Analysis (EXPM:OCEA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:OCEA)

This stock is for swing trading only.

It was at the basement price per share and it is starting to climb up from the low prices per share.
coolfooldumbguy - February 11, 2025

Positive News from Joint Venture Partner! Good news for OCEA

OCEA Update: Positive News from Joint Venture Partner! Good news for OCEA! Their joint venture partner, Virion Therapeutics...
Prabhjitk - June 12, 2024

OCEA.... NR this a.m

  Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With...
Iseneschal - June 26, 2023

OCEA....Here it goes...over $7 in PM trading

$7.34 Cheers !
Iseneschal - June 23, 2023

OCEA....Let gooooooo !

$17 holla ?
Iseneschal - June 22, 2023

OCEA....You know this is going higher....

especially after this a.m's retracement to sub $6....added a position just above $6 this a.m ; ) They announced a price target of...
Iseneschal - June 22, 2023
View more Bullboard ››

Almonty Industries Inc.

Almonty Industries Inc.

Almonty Industries Inc. engages in mining, processing, and shipping of tungsten concentrate. The company explores for tin and ...
View More »

Podcasts